Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|April 17, 2023
Peptidoglycan from <i>Bacillus anthracis</i> Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3Joshua S Mytych, Zijian Pan, Charmaine Lopez-Davis, et al.
Immunohorizons|March 22, 2024
Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3Joshua S Mytych, Zijian Pan, Charmaine Lopez-Davis, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 27, 2019
Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessmentJadith Ziegler, Michelle Zalles, Nataliya Smith, et al.
Oncotarget|October 27, 2017
AG488 as a therapy against gliomasJadith Ziegler, Anja Bastian, Megan Lerner, et al.
Free Radical Biology & Medicine|June 30, 2015
OKN-007 decreases free radical levels in a preclinical F98 rat glioma modelPatricia Coutinho de Souza, Nataliya Smith, Oluwatomisin Atolagbe, et al.
Cellular Immunology|June 19, 2026
Persistent CD4<sup>+</sup> T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infectionJadith Ziegler, Christina Lawrence, Nathan Pezant, et al.
Urology|March 17, 2018
Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder PermeabilityBeverley Greenwood-Van Meerveld, Ehsan Mohammadi, Rocco Latorre, et al.
Journal of Cellular and Molecular Medicine|December 22, 2019
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse modelMichelle Zalles, Nataliya Smith, Jadith Ziegler, et al.
Neuro-Oncology|July 16, 2016
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma modelsJadith Ziegler, Richard Pody, Patricia Coutinho de Souza, et al.
Translational Oncology|November 24, 2018
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor GrowthRheal A Towner, Nataliya Smith, Debra Saunders, et al.
Pageof 1